Lemonade, Inc. (NYSE:LMND – Get Free Report) insider John Sheldon Peters sold 1,790 shares of the stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $45.50, for a total value of $81,445.00. Following the transaction, the insider now owns 88,493 shares of the company’s stock, valued at approximately $4,026,431.50. This trade represents a 1.98 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.
Lemonade Trading Down 3.9 %
Shares of LMND traded down $1.64 during midday trading on Monday, reaching $39.90. The stock had a trading volume of 1,589,037 shares, compared to its average volume of 1,826,088. The firm has a market cap of $2.85 billion, a PE ratio of -13.13 and a beta of 2.09. The firm has a 50 day simple moving average of $34.10 and a 200-day simple moving average of $23.47. Lemonade, Inc. has a one year low of $14.03 and a one year high of $53.85.
Lemonade (NYSE:LMND – Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported ($0.95) EPS for the quarter, topping analysts’ consensus estimates of ($1.02) by $0.07. The business had revenue of $136.60 million during the quarter, compared to analysts’ expectations of $129.10 million. Lemonade had a negative return on equity of 32.85% and a negative net margin of 43.51%. Lemonade’s quarterly revenue was up 19.3% on a year-over-year basis. During the same quarter last year, the company posted ($0.88) earnings per share. As a group, research analysts forecast that Lemonade, Inc. will post -3.04 EPS for the current fiscal year.
Institutional Investors Weigh In On Lemonade
Analyst Upgrades and Downgrades
Several equities research analysts have commented on the company. Keefe, Bruyette & Woods cut Lemonade from a “market perform” rating to an “underperform” rating and boosted their target price for the company from $18.00 to $21.00 in a research note on Thursday, November 7th. Jefferies Financial Group reduced their target price on shares of Lemonade from $15.00 to $14.00 and set an “underperform” rating for the company in a report on Wednesday, October 9th. BMO Capital Markets lifted their price target on shares of Lemonade from $13.00 to $15.00 and gave the company an “underperform” rating in a research note on Thursday, November 21st. Piper Sandler increased their price objective on shares of Lemonade from $25.00 to $44.00 and gave the stock a “neutral” rating in a research note on Thursday, November 21st. Finally, Morgan Stanley raised Lemonade from an “underweight” rating to an “equal weight” rating and lifted their target price for the company from $23.00 to $42.00 in a research report on Wednesday, November 20th. Three research analysts have rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Lemonade has an average rating of “Hold” and a consensus price target of $30.43.
Get Our Latest Research Report on LMND
About Lemonade
Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.
Featured Stories
- Five stocks we like better than Lemonade
- How to Find Undervalued Stocks
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- What is Insider Trading? What You Can Learn from Insider Trading
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- Best Stocks Under $5.00
- Market Overreaction: 2 Stocks to Buy on the Way Down
Receive News & Ratings for Lemonade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lemonade and related companies with MarketBeat.com's FREE daily email newsletter.